Department of Microbiology, St Vincent's Hospital, Melbourne, Victoria, Australia.
Pharmacy Department, St Vincent's Hospital, Melbourne, Victoria, Australia.
J Hosp Infect. 2017 Jun;96(2):111-115. doi: 10.1016/j.jhin.2017.02.010. Epub 2017 Feb 16.
Reports of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-Kp) in Australia were previously uncommon, with cases imported sporadically by travellers from higher prevalence countries.
The study institution reported the first outbreak of KPC-Kp in Australia. The aim of this study was to identify risk factors for KPC-Kp colonization and infection using a matched case-control study.
The study included all hospitalized patients with KPC-Kp colonization or infection from January 2012 to September 2015.
Thirty-four cases of KPC-producing Enterobacteriaceae (including 31 KPC-Kp cases) were matched with 136 controls. Variables associated with KPC-Kp acquisition included: length of hospital stay >28 days in the past 12 months, prior vancomycin-resistant enterococci (VRE) colonization, central venous catheter (CVC), gastrointestinal disease and invasive procedures. Exposure to broad-spectrum antibiotics was also found to be a significant risk factor. In the multi-variate analysis, three factors independently associated with KPC-Kp acquisition were length of hospital stay >28 days in the past 12 months [odds ratio (OR) 23.6, 95% confidence interval (CI) 4.9-113.3], presence of a CVC (OR 15.4, 95% CI 2.7-86.9), and prior VRE colonization (OR 6.0, 95% CI 1.6-23.2). Very few patients had a history of overseas travel.
This study demonstrates that patients with prolonged hospital exposure are more likely to acquire KPC-Kp in the setting of a local outbreak, and suggests that risk factors for KPC-Kp acquisition may be shared with those for VRE colonization. Local screening strategies targeting overseas travellers would likely miss many cases. The results of this study will help to inform screening policies for carbapenemase-producing Enterobacteriaceae.
此前,澳大利亚报告的产碳青霉烯酶肺炎克雷伯菌(KPC)的肺炎克雷伯菌(KPC-Kp)病例并不常见,这些病例都是由来自高流行国家的旅行者零星输入的。
该研究机构报告了澳大利亚首例 KPC-Kp 爆发。本研究的目的是通过匹配的病例对照研究确定 KPC-Kp 定植和感染的危险因素。
该研究纳入了 2012 年 1 月至 2015 年 9 月期间所有有 KPC 生产性肠杆菌科定植或感染的住院患者。
34 例产碳青霉烯酶肠杆菌科(包括 31 例 KPC-Kp 病例)与 136 例对照相匹配。与 KPC-Kp 获得相关的变量包括:过去 12 个月中住院时间>28 天、既往耐万古霉素肠球菌(VRE)定植、中心静脉导管(CVC)、胃肠道疾病和有创操作。广谱抗生素的暴露也被认为是一个显著的危险因素。在多变量分析中,与 KPC-Kp 获得独立相关的三个因素是过去 12 个月中住院时间>28 天[比值比(OR)23.6,95%置信区间(CI)4.9-113.3]、存在 CVC(OR 15.4,95%CI 2.7-86.9)和既往 VRE 定植(OR 6.0,95%CI 1.6-23.2)。很少有患者有海外旅行史。
本研究表明,在当地爆发期间,有长时间住院暴露史的患者更有可能获得 KPC-Kp,并且提示 KPC-Kp 获得的危险因素可能与 VRE 定植的危险因素相同。针对海外旅行者的本地筛查策略可能会错过许多病例。本研究的结果将有助于为产碳青霉烯酶肠杆菌科的筛查策略提供信息。